Evidence map›Paper›PMID 39196501›Full record

ReviewDrug delivery and translational research2025

Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds.

Mattia D Langellotto, Giovanna Rassu, Carla Serri, Sara Demartis, Paolo Giunchedi, Elisabetta Gavini

Abstract readReview
In one paragraph

Review in Drug delivery and translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Green nanomedicine for cancer therapy.Chinese medical journal · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Engineered bone-targetingMaterials today. Bio · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mattia D LangellottoPhD Program in Biomedical Sciences - Neuroscience, Department of Biomedical Sciences, University of Sassari, Sassari, 07100, Italy.
Giovanna RassuDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/a, Sassari, 07100, Italy. grassu@uniss.it.ORCID 0000-0001-6268-8179
Carla SerriDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/a, Sassari, 07100, Italy.
Sara DemartisDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/a, Sassari, 07100, Italy.
Paolo GiunchediDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/a, Sassari, 07100, Italy.
Elisabetta GaviniDepartment of Medicine, Surgery and Pharmacy, University of Sassari, Via Muroni 23/a, Sassari, 07100, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes are extracellular nanovesicles secreted by all cell types and have been studied to understand and treat many human diseases. Exosomes are involved in numerous physiological and pathological processes, intercellular communication, and the transfer of substances. Over the years, several studies have explored mammalian-derived exosomes for therapeutic and diagnostic uses. Only recently have plant-derived extracellular vesicles (EVs) attracted attention for their ability to overcome many defects associated with using mammalian-derived extracellular vesicles, such as safety and scale-up issues. The ease of large-scale production, low toxicity, low immunogenicity, efficient cellular uptake, high biocompatibility, and high stability of these nanovesicles make them attractive for drug delivery systems. In addition, their native contents of proteins, miRNAs and secondary metabolites could be exploited for pharmaceutical applications in combination with other drugs. The present review intends to provide adequate tools for studying and developing drug delivery systems based on plant-derived EVs. Therefore, indications concerning extraction methods, characterisation, and drug loading will be offered. Their biological composition and content will also be reported. Finally, the current applications of these systems as nanocarriers for pharmacologically active substances will be shown.

Indexed as

Biological ProductsDrug Delivery SystemsExtracellular VesiclesPlantsAnimalsDrug CarriersHumansBiological ProductsDrug CarriersBioactiveDrug delivery systemExosomeNanoparticlesNanovesiclesPlant-derived extracellular vesicles

Identifiers

PMID39196501
PMCPMC11782344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.